PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product Small molecules - Market size and forecast 2018-2023 Biologics - Market size and forecast 2018-2023 Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 South America - Market size and forecast 2018-2023 MEA - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Growing use of analytics by CDMOs Growing demand for CDMOs for cell and gene therapies Increasing market consolidation PART 12: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Aenova Holding GmbH Almac Group Ltd. Catalent Inc. FAMAR Health Care Services FAREVA SA Lonza Group Ltd. Recipharm AB Siegfried Holding AG The Lubrizol Corp. Thermo Fisher Scientific Inc. PART 14: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO Exhibit 01: Vendors: Key product offerings Exhibit 02: Global pharmaceuticals market Exhibit 03: Segments of global pharmaceuticals market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ billions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: Small molecules - Market size and forecast 2018-2023 ($ billions) Exhibit 21: Small molecules - Year-over-year growth 2019-2023 (%) Exhibit 22: Biologics - Market size and forecast 2018-2023 ($ billions) Exhibit 23: Biologics - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2018-2023 ($ billions) Exhibit 29: North America - Year-over-year growth 2019-2023 (%) Exhibit 30: Europe - Market size and forecast 2018-2023 ($ billions) Exhibit 31: Europe - Year-over-year growth 2019-2023 (%) Exhibit 32: APAC - Market size and forecast 2018-2023 ($ billions) Exhibit 33: APAC - Year-over-year growth 2019-2023 (%) Exhibit 34: South America - Market size and forecast 2018-2023 ($ billions) Exhibit 35: South America - Year-over-year growth 2019-2023 (%) Exhibit 36: MEA - Market size and forecast 2018-2023 ($ billions) Exhibit 37: MEA - Year-over-year growth 2019-2023 (%) Exhibit 38: Key leading countries Exhibit 39: Market opportunity Exhibit 40: Impact of drivers and challenges Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Aenova Holding GmbH - Vendor overview Exhibit 47: Aenova Holding GmbH – Service segments Exhibit 48: Aenova Holding GmbH - Organizational developments Exhibit 49: Aenova Holding GmbH - Key offerings Exhibit 50: Almac Group Ltd. - Vendor overview Exhibit 51: Almac Group Ltd. - Product segments Exhibit 52: Almac Group Ltd. - Organizational developments Exhibit 53: Almac Group Ltd. - Key offerings Exhibit 54: Catalent Inc. - Vendor overview Exhibit 55: Catalent Inc. - Business segments Exhibit 56: Catalent Inc. - Organizational developments Exhibit 57: Catalent Inc. - Geographic focus Exhibit 58: Catalent Inc. - Segment focus Exhibit 59: Catalent Inc. - Key offerings Exhibit 60: FAMAR Health Care Services - Vendor overview Exhibit 61: FAMAR Health Care Services - Service segments Exhibit 62: FAMAR Health Care Services - Organizational developments Exhibit 63: FAMAR Health Care Services - Key offerings Exhibit 64: FAREVA SA - Vendor overview Exhibit 65: FAREVA SA - Business segments Exhibit 66: FAREVA SA - Organizational developments Exhibit 67: FAREVA SA - Key offerings Exhibit 68: Lonza Group Ltd. - Vendor overview Exhibit 69: Lonza Group Ltd. - Business segments Exhibit 70: Lonza Group Ltd. - Organizational developments Exhibit 71: Lonza Group Ltd. - Geographic focus Exhibit 72: Lonza Group Ltd. - Segment focus Exhibit 73: Lonza Group Ltd. - Key offerings Exhibit 74: Recipharm AB - Vendor overview Exhibit 75: Recipharm AB - Business segments Exhibit 76: Recipharm AB - Organizational developments Exhibit 77: Recipharm AB - Geographic focus Exhibit 78: Recipharm AB - Segment focus Exhibit 79: Recipharm AB - Key offerings Exhibit 80: Siegfried Holding AG - Vendor overview Exhibit 81: Siegfried Holding AG - Product segments Exhibit 82: Siegfried Holding AG - Organizational developments Exhibit 83: Siegfried Holding AG - Segment focus Exhibit 84: Siegfried Holding AG - Key offerings Exhibit 85: The Lubrizol Corp. - Vendor overview Exhibit 86: The Lubrizol Corp. - Business segments Exhibit 87: The Lubrizol Corp. - Organizational developments Exhibit 88: The Lubrizol Corp. - Key offerings Exhibit 89: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 90: Thermo Fisher Scientific Inc. - Business segments Exhibit 91: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 92: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 93: Thermo Fisher Scientific Inc. - Segment focus Exhibit 94: Thermo Fisher Scientific Inc. - Key offerings Exhibit 95: Validation techniques employed for market sizing Exhibit 96: Definition of market positioning of vendors

Aenova Holding GmbH, Almac Group Ltd., Catalent Inc., FAMAR Health Care Services, FAREVA SA, Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, The Lubrizol Corp., and Thermo Fisher Scientific Inc.